Displaying 1-10 of 55.

FDA Approves Imbruvica (Ibrutinib) for Chronic Lymphocytic ...

The US Food and Drug Administration has approved the use of Imbruvica
(ibrutinib) to treat some people with chronic lymphocytic leukemia (CLL). ...

http://www.cancer.org/cancer/news/news/fda-approves-imbruvica-ibrutinib-for-chronic-lymphocytic-leukemia

Ibrutinib

Ibrutinib is a type of targeted therapy called a tyrosine kinase inhibitor used
to treat mantle cell lymphoma. ... Text Size. Ibrutinib. (eye-broo-tuh-nib). ...

http://www.cancer.org/treatment/treatmentsandsideeffects/guidetocancerdrugs/ibrutinib

FDA Approves Ibrutinib for Mantle Cell Lymphoma

The US Food and Drug Administration (FDA) has approved ibrutinib
(Imbruvica) to treat some people with mantle cell lymphoma. ...

http://www.cancer.org/cancer/news/news/fda-approves-ibrutinib-for-mantle-cell-lymphoma

Drug Shows Promise for Mantle Cell Lymphoma and Chronic ...

Ibrutinib, a new drug under development, is showing promise as a treatment
for mantle cell lymphoma and chronic lymphocytic leukemia (CLL ...

http://www.cancer.org/cancer/news/news/drug-shows-promise-for-mantle-cell-lymphoma-and-chronic-lymphocytic-leukemia

FDA Approves Ibrutinib for Mantle Cell Lymphoma

The US Food and Drug Administration (FDA) has approved ibrutinib
(Imbruvica) to treat some people with mantle cell lymphoma. ...

http://www.cancer.org/cancer/news/fda-approves-ibrutinib-for-mantle-cell-lymphoma

Drug Shows Promise for Mantle Cell Lymphoma and Chronic ...

Ibrutinib, a new drug under development, is showing promise as a treatment
for mantle cell lymphoma and chronic lymphocytic leukemia (CLL ...

http://www.cancer.org/cancer/news/drug-shows-promise-for-mantle-cell-lymphoma-and-chronic-lymphocytic-leukemia

News By Topic

... READ MORE ». FDA Approves Ibrutinib for Mantle Cell Lymphoma. The
US Food and Drug Administration (FDA) has approved ...

http://www.cancer.org/cancer/news/newsbytopic/index?topic=non-hodgkin+lymphoma

News By Topic

... leukemia - chronic lymphocytic (cll). FDA Approves Imbruvica (Ibrutinib)
for Chronic Lymphocytic Leukemia. The US Food ...

http://www.cancer.org/cancer/news/newsbytopic/index?topic=leukemia+-+chronic+lymphocytic+(cll)

News By Topic

... leukemia - chronic lymphocytic (cll). FDA Approves Imbruvica (Ibrutinib)
for Chronic Lymphocytic Leukemia. The US Food ...

http://www.cancer.org/cancer/news/newsbytopic/index?topic=leukemia%20-%20chronic%20lymphocytic%20(cll)

News By Topic

... READ MORE ». FDA Approves Ibrutinib for Mantle Cell Lymphoma. The
US Food and Drug Administration (FDA) has approved ...

http://www.cancer.org/cancer/news/newsbytopic/index?topic=non-hodgkin%20lymphoma